---

---

entities : Novartis ag   

save search

---

Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published: 2023-12-12 (Crawled : 20:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| 28.85% | O: -10.21% H: 0.0% C: 0.0%
GIKLY | $4.4 -3.93% 132.75% 0 |

Manufacturing

| -38.8% | O: 2.92% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 0.18% | O: 0.71% H: 0.88% C: 0.85%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 9.5% | O: -0.17% H: 1.17% C: 0.86%
DNLI | $15.56 -3.41% -3.6% 40 |

Health Technology

| -19.34% | O: 2.9% H: 8.82% C: 8.56%
BIIB | $201.99 4.56% 4.32% 420 |

Health Technology

| -18.89% | O: 0.09% H: 2.58% C: 2.52%
america disease alzheimer's therapeutics growth market

---

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 6.8K |

Health Technology

| -20.5% | O: -0.42% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
ALPMY | News | $9.47 -0.21% -1.11% 20K |

Manufacturing

| -20.29% | O: -5.13% H: 5.41% C: 3.46%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.1% | O: 0.45% H: 0.75% C: 0.46%
ORTX | $16.7 0.0% 370K |

Health Technology

| 2.15% | O: 0.18% H: 0.43% C: 0.25%
GBIO | News | $2.99 -8.28% -8.85% 7 |

Health Technology

| 67.98% | O: 5.62% H: 3.72% C: -4.26%
BIIB | $201.99 4.56% 4.32% 420 |

Health Technology

| -17.93% | O: 0.59% H: 1.35% C: 0.6%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.32% | O: 1.83% H: 0.04% C: -1.13%
ADAP | $1.08 -5.26% -5.07% 790K |

Health Technology

| 114.93% | O: -0.46% H: 5.56% C: -1.12%
ABEO | News | $3.17 -7.04% -7.74% 3.9K |

Health Technology

| -31.24% | O: 0.65% H: 2.59% C: 0.86%
america therapy growth market

---

Radiopharmaceuticals market size to grow by USD 4.37 billion from 2021 to 2026 | Actinium Pharmaceuticals Inc., Bayer AG, Bracco Spa, BWX Technologies Inc. and more among the key companies in the market - Technavio
Published: 2023-12-12 (Crawled : 06:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.1% | O: 0.45% H: 0.75% C: 0.46%
FUSN | $21.4 -0.09% -0.09% 320 |

Health Technology

| 330.58% | O: 2.01% H: 4.73% C: 3.55%
companies pharmaceuticals market

---

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 8.11% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $577.39 0.49% -0.38% 1.7M |

Health Technology

| 17.52% | O: 0.86% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.1% | O: 0.45% H: 0.75% C: 0.46%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 11.24% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 0.51% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 12.13% | O: 1.54% H: 0.06% C: -0.78%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.32% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

---

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.1% | O: 0.45% H: 0.75% C: 0.46%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.32% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

---

Low-Density Lipoprotein Test Global Market Report 2023, By Product Type (LDL-C; LDL-P; LDL-B) , By Component, By Disease Type, By Distribution Channel and By End User
Published: 2023-12-11 (Crawled : 17:00) - prnewswire.com
QGEN | $41.52 -0.88% 0.0% 820K |

Health Technology

| -0.7% | O: -0.02% H: 0.9% C: 0.77%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.13% | O: 0.75% H: 0.55% C: 0.27%
DHR | $250.41 -1.07% -0.46% 2.3M |

Health Technology

| 15.14% | O: 0.27% H: 1.66% C: 1.5%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| 2.52% | O: 0.09% H: 0.0% C: 0.0%
QGEN | $41.52 -0.88% 0.0% 820K |

Health Technology

| -0.7% | O: -0.02% H: 0.9% C: 0.77%
disease report test distribution global market

---

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
ERAS | $1.88 -2.59% -2.66% 0 |

| 0.53% | O: 1.07% H: 0.0% C: -2.65%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.13% | O: 0.75% H: 0.55% C: 0.27%
fda melanoma granted designation advanced

---

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Published: 2023-12-11 (Crawled : 07:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.13% | O: 0.75% H: 0.55% C: 0.27%
novartis study

---

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.13% | O: 0.75% H: 0.55% C: 0.27%
fabhalta novartis trial results

---

S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2023 Review Results
Published: 2023-12-08 (Crawled : 23:00) - prnewswire.com
TCEHY | News | $43.85 3.23% 0.04% 3.8M |

Information

| Email alert Add to watchlist
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| Email alert Add to watchlist
TCTZF | News | $43.55 2.25% 2.11% 6.3K |

Technology Services

| Email alert Add to watchlist
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| Email alert Add to watchlist
SPGI | News | $413.28 0.01% 0.26% 2.8M |

Commercial Services

| Email alert Add to watchlist
DNOW | $14.77 -2.51% 0.0% 740K |

Distribution Services

| Email alert Add to watchlist
jones review results

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
PFE | News 4 | $26.27 -0.19% 0.19% 18M |

Health Technology

| -8.24% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.52% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| 60.0% | O: -20.0% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
PPCB | $0.0011 -41.86% 5.6M |

Manufacturing

| -88.7% | O: 0.0% H: 2.61% C: -4.35%
PFE | News 4 | $26.27 -0.19% 0.19% 18M |

Health Technology

| -8.24% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.52% | O: 0.19% H: 0.35% C: 0.2%
active market

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published: 2023-12-08 (Crawled : 14:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
PFE | News 4 | $26.27 -0.19% 0.19% 18M |

Health Technology

| -8.24% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.52% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 6.8K |

Health Technology

| -23.05% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 3.78% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | News | $9.47 -0.21% -1.11% 20K |

Manufacturing

| -22.76% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -6.04% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 30.32% | O: -0.42% H: 0.67% C: 0.25%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 2.52% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -5.02% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 28.23% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| -2.59% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 13.54% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 3.77% | O: 1.07% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 2.5K |

Health Technology

| -14.06% | O: 0.08% H: 1.45% C: 1.17%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.63% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

FDA Approves Bio-Thera Solutions' Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.34% | O: -0.97% H: 0.3% C: -0.19%
avzivi fda biosimilar

---

Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 2.05% | O: -1.66% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.34% | O: -0.97% H: 0.3% C: -0.19%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -6.55% | O: -1.61% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 15.77% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 2.54% | O: -1.19% H: 0.0% C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K |

Health Technology

| 8.47% | O: 0.51% H: 1.22% C: 1.09%
IMNM | $14.27 -2.66% -2.66% 560K |

Health Technology

| 82.02% | O: -0.64% H: 1.67% C: -1.16%
BIIB | $201.99 4.56% 4.32% 420 |

Health Technology

| -13.63% | O: 1.67% H: 0.91% C: 0.57%
antibody therapeutics market

---

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 12.08% | O: 1.64% H: 0.0% C: -1.33%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.42% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 12.47% | O: -0.03% H: 0.28% C: -0.41%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 29.05% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 16.07% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $15.56 -3.41% -3.6% 40 |

Health Technology

| -16.07% | O: 0.05% H: 5.74% C: 3.18%
BIIB | $201.99 4.56% 4.32% 420 |

Health Technology

| -12.01% | O: 0.42% H: 2.37% C: 1.45%
disease parkinson's revenue research therapeutics market

---

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Published: 2023-12-06 (Crawled : 00:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.42% | O: 0.52% H: 0.18% C: -0.43%
fabhalta fda first approval offering novartis

---

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 12.08% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 7.63% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.42% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 12.47% | O: -0.03% H: 0.28% C: -0.41%
BAX | $40.93 -0.22% 0.0% 3 |

Health Technology

| 14.33% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 16.07% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 11.23% | O: 0.73% H: 0.06% C: -1.38%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.79% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News 4 | $159.13 0.55% 0.58% 290K |

Technology Services

| 23.36% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News 4 | $161.1 0.74% 0.7% 180K |

Technology Services

| 23.57% | O: 1.97% H: 0.0% C: 0.0%
ADBE A | $477.12 0.89% 0.96% 1.7M |

Technology Services

| -20.77% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

---

Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 6.8K |

Health Technology

| -19.35% | O: 0.26% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 7.88% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 0.11% | O: 0.27% H: 0.12% C: 0.12%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| -1.99% | O: -1.1% H: 0.0% C: 0.0%
ALPMY | News | $9.47 -0.21% -1.11% 20K |

Manufacturing

| -21.74% | O: 0.0% H: 0.5% C: 0.17%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| -0.65% | O: -1.86% H: 0.34% C: -0.19%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 11.55% | O: -1.01% H: 0.39% C: 0.19%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 17.03% | O: 0.51% H: 0.68% C: 0.32%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 1.41% | O: -0.5% H: 0.0% C: 0.0%
GLMD | $0.4 10.68% 6.18% 590 |

Health Technology

| 2.59% | O: 0.03% H: 2.44% C: -1.03%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 0.17% | O: -0.25% H: 0.05% C: -0.37%
america market

---

Gainers vs Losers

61%

39%

Top 10 Gainers

BOF | $2.08 77.78% 39.06% 110M |

BHIL | $0.1793 -4.37% 19.24% 340K |

Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K |

CI | $352.28 -0.11% 13.53% 2 |

Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K |

n/a

MTH | $154.69 -2.21% 12.68% 450K |

Consumer Durables

HCP | News | $31.41 7.75% 11.26% 1.2M |

BMTX 4 | $1.545 0.98% 10.03% 2.5K |

Information

TAL | $12.26 0.57% 9.22% 12M |

Consumer Services

ASXC | $0.243 -2.41% 7.0% 1.1M |

Manufacturing

---

Your saved searches

---